Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Gallium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 22,011Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Methodist’s Generics Gallium68 Edotreotide Receive Approval in US
    Methodist’s Generics Gallium68 Edotreotide Receive Approval in US

    10 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218845

    FDA
    10 Oct 2025
    Share Share
    CMS Grants Transitional Pass-Through Status for Gozellix
    CMS Grants Transitional Pass-Through Status for Gozellix

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154891/0/en/CMS-Grants-Transitional-Pass-Through-Status-for-Gozellix.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    Telix Begins Phase 3 BiPASS Trial: PSMA-PET for Prostate Cancer
    Telix Begins Phase 3 BiPASS Trial: PSMA-PET for Prostate Cancer

    09 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/09/3147425/0/en/Telix-Doses-First-Patient-in-Phase-3-BiPASS-Trial-PSMA-PET-Imaging-for-Prostate-Cancer-Diagnosis.html

    GLOBENEWSWIRE
    09 Sep 2025
    Share Share
    Gozellix Granted Permanent HCPCS Code
    Gozellix Granted Permanent HCPCS Code

    09 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/09/3112948/0/en/Gozellix-Receives-Permanent-HCPCS-Code.html

    GLOBENEWSWIRE
    09 Jul 2025
    Share Share
    Telix partners with Cardinal Health for Gozellix distribution
    Telix partners with Cardinal Health for Gozellix distribution

    08 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/08/3057434/0/en/Telix-Announces-Cardinal-Health-for-Gozellix-Commercial-Distribution.html

    GLOBENEWSWIRE
    08 Apr 2025
    Share Share
    ARTMS Drug Master File for Gallium Production Technology Referenced
    ARTMS Drug Master File for Gallium Production Technology Referenced

    01 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/01/3053398/0/en/ARTMS-Drug-Master-File-for-Gallium-Production-Technology-Referenced-with-Telix-s-Gozellix.html

    GLOBENEWSWIRE
    01 Apr 2025
    Share Share